Vialwirebiotech, curated
August 16, 2026, 4:17 PM
August 7, 2026
- 4:38 PM · SCMP — Tech4:38 PMUS judge blocks Pentagon’s ‘Chinese military’ label for WuXi AppTec — SCMP — Tech
- 12:31 PM · STAT News
- 12:00 PM · BioWorld12:00 PMLatigo raises $346M in IPO for non-opioid Nav1.8 pain pipeline — BioWorld
- 12:00 PM · BioWorld12:00 PMBlossomhill’s $150M IPO to fund macrocyclic cancer drug pipeline — BioWorld
- 10:02 AM · BioPharma Dive10:02 AM‘Significant’ demand for Revolution drug; Intellia pinpoints liver toxicity culprit — BioPharma Dive
- 9:57 AM · BioPharma Dive9:57 AMWhy Big Pharma is chasing the industry’s most-powerful supercomputer — BioPharma Dive
- 9:00 AM · BioWorld9:00 AMNonpsychedelic 5-HT2AR agonist boosts colorectal cancer immunity — BioWorld
- 9:00 AM · BioWorld9:00 AMShape Therapeutics advances SHP-401 for Rett syndrome — BioWorld
- 9:00 AM · BioWorld9:00 AMInsilico Medicine nominates ISM-9077 as ocular candidate — BioWorld
- 9:00 AM · BioWorld9:00 AMCSPC’s RSV vaccine SYS-6057 cleared for clinic in China — BioWorld
- 9:00 AM · BioWorld9:00 AMIPS Heart’s ISX9-CPC designated rare pediatric drug by FDA — BioWorld
- 7:00 AM · Drug Discovery World7:00 AMEvotec joins Odyssey in autoimmune drug development — Drug Discovery World
- 6:05 AM · Pharmaceutical Technology6:05 AMContext drops bispecific T-cell engager on cost-cutting initiative — Pharmaceutical Technology
- 4:43 AM · Pharmaceutical Technology4:43 AMMediar and Ono Pharmaceutical to develop fibro-inflammatory treatments — Pharmaceutical Technology
- 4:25 AM · Drug Discovery World4:25 AMTrial shows significant improvements in early Parkinson’s disease — Drug Discovery World
- 12:00 AM · SCMP — Tech12:00 AMWhat China’s expanded funding for HIV/Aids in Africa means as US cuts health aid — SCMP — Tech
August 6, 2026
- 5:21 PM · BioWorld5:21 PMTarsus gains Stargardt asset with $800M Alkeus buy — BioWorld